Skip to main content
Top
Published in: BMC Neurology 1/2023

Open Access 01-12-2023 | Guillain-Barré Syndrome | Case report

Is Guillain–Barre syndrome following chickenpox a parainfectious disease? A case report and literature review

Authors: Bademain Jean Fabrice Ido, Sidi Mahamoud Guebre, Emeline Agathe Carama, Alfred Anselme Dabilgou, Christian Napon

Published in: BMC Neurology | Issue 1/2023

Login to get access

Abstract

Background

Polyradiculoneuropathy following infection with varicella zoster virus (VZV) is rare and most of the time, happens in the context of reactivation of latent VZV. We report a case of acute polyradiculoneuropathy following primary infection with VZV marked by atypical clinical features raising the hypothesis of a para-infectious disease.

Case presentation

We describe a 43-years-old male who developed ataxia, dysphagia, dysphonia, and oculomotor disorders (vertical binocular diplopia and bilateral ptosis) followed by quadriplegia with areflexia which occurred 4 days later. The patient had a history of varicella that occurred 10 days before the onset of these symptoms. Nerve conduction study revealed features consistent with an acute motor-sensory axonal neuropathy (AMSAN). Anti-ganglioside antibodies were negative.
Based on clinical presentation and ancillary examination, we retain the Miller Fisher/Guillain-Barré overlap syndrome diagnosis.
The patient was treated with high doses of methylprednisolone but the evolution of the disease was nevertheless marked by a complete recovery six weeks after onset of symptoms.

Conclusion

GBS following varicella is a rare but severe disease occurring most often in adults and marked by greater involvement of the cranial nerves. Its clinical features suggest that it is a para-infectious disease. Antiviral therapy has no effect on the course of the disease but its administration within the first 24 h after the onset of chickenpox in adults can prevent its occurrence.
Literature
1.
go back to reference Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007–2017: What has changed? Trop Med Int Health. 2019;24:132–42.CrossRefPubMed Wachira VK, Peixoto HM, de Oliveira MRF. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007–2017: What has changed? Trop Med Int Health. 2019;24:132–42.CrossRefPubMed
2.
go back to reference Esposito S, Longo MR. Guillain-Barré syndrome Autoimmune Rev. 2017;16:96–101. Esposito S, Longo MR. Guillain-Barré syndrome Autoimmune Rev. 2017;16:96–101.
3.
go back to reference Islam B, Islam Z, Geurtsvankessel CH, Jahan I, Endtz HP, Mohammad QD, et al. Guillain-Barré syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. 2018;37:511–8.CrossRefPubMed Islam B, Islam Z, Geurtsvankessel CH, Jahan I, Endtz HP, Mohammad QD, et al. Guillain-Barré syndrome following varicella-zoster virus infection. Eur J Clin Microbiol Infect Dis. 2018;37:511–8.CrossRefPubMed
4.
go back to reference Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis. 2010;14(2):e161–3.CrossRefPubMed Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis. 2010;14(2):e161–3.CrossRefPubMed
5.
go back to reference Lompo LD, Maitrot A, Aubertin A, Khatib M, Decombes R, Billaud B. Miller Fisher syndrome on the borders of Guillain-Barre syndrome: about one case and review of literature. Clin Med Rep. 2018;1(1):1–5. Lompo LD, Maitrot A, Aubertin A, Khatib M, Decombes R, Billaud B. Miller Fisher syndrome on the borders of Guillain-Barre syndrome: about one case and review of literature. Clin Med Rep. 2018;1(1):1–5.
6.
go back to reference Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007;36(5):615–27.CrossRefPubMed Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007;36(5):615–27.CrossRefPubMed
7.
go back to reference Kang JH, Sheu JJ, Lin HC. Increased Risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis. 2010;51:525–30.CrossRefPubMed Kang JH, Sheu JJ, Lin HC. Increased Risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis. 2010;51:525–30.CrossRefPubMed
8.
go back to reference Anderson TC, Leung JW, Harpaz R, Dooling KL. Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010–2018. Hum Vaccin Immunother. 2021;17(12):5304–10.CrossRefPubMedPubMedCentral Anderson TC, Leung JW, Harpaz R, Dooling KL. Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010–2018. Hum Vaccin Immunother. 2021;17(12):5304–10.CrossRefPubMedPubMedCentral
9.
go back to reference Fillet AM. Histoire naturelle de l’infection à VZV : physiopathologie, mécanisme d’action et critères virologiques d’évaluation des antiviraux. Méd Mal Infect. 1998;28(spécial):767–74.CrossRef Fillet AM. Histoire naturelle de l’infection à VZV : physiopathologie, mécanisme d’action et critères virologiques d’évaluation des antiviraux. Méd Mal Infect. 1998;28(spécial):767–74.CrossRef
10.
go back to reference Cortese A, Tavazzi E, Delbue S, Alfonsi E, Pichiecchio A, Ceroni M, Ferrante P, Marchioni E. Varicella zoster virus-associated polyradiculoneuritis. Neurology. 2009;73(16):1334–5.CrossRefPubMed Cortese A, Tavazzi E, Delbue S, Alfonsi E, Pichiecchio A, Ceroni M, Ferrante P, Marchioni E. Varicella zoster virus-associated polyradiculoneuritis. Neurology. 2009;73(16):1334–5.CrossRefPubMed
11.
go back to reference Najjar S, Najjar A, Chong DJ, Pramanik DK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.CrossRefPubMedPubMedCentral Najjar S, Najjar A, Chong DJ, Pramanik DK, Kirsch C, Kuzniecky RI, Pacia SV, Azhar S. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17:231.CrossRefPubMedPubMedCentral
12.
go back to reference Tatarelli P, Garnero M, Del Bono V, Camera M, Schenone A, Grandis M, Benedetti L, Viscoli C. Guillain-Barré syndrome following chickenpox: a case series. Int J Neurosci. 2016;126:478–9.CrossRefPubMed Tatarelli P, Garnero M, Del Bono V, Camera M, Schenone A, Grandis M, Benedetti L, Viscoli C. Guillain-Barré syndrome following chickenpox: a case series. Int J Neurosci. 2016;126:478–9.CrossRefPubMed
13.
go back to reference Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12:1175–89.CrossRefPubMed Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya JM, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12:1175–89.CrossRefPubMed
14.
go back to reference Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of the tropism of varicella-zoster virus pathogenesis. Nat Rev Microbiol. 2014;12(3):197–210.CrossRefPubMedPubMedCentral Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of the tropism of varicella-zoster virus pathogenesis. Nat Rev Microbiol. 2014;12(3):197–210.CrossRefPubMedPubMedCentral
15.
16.
go back to reference Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med. 2009;38:673–88.CrossRefPubMed Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med. 2009;38:673–88.CrossRefPubMed
17.
go back to reference Guillain-Barré syndrome steroid trial group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet. 1993;341:586–90. Guillain-Barré syndrome steroid trial group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet. 1993;341:586–90.
18.
go back to reference Hugues RAC, Newsom-David JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750–3.CrossRef Hugues RAC, Newsom-David JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750–3.CrossRef
20.
go back to reference Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–6.CrossRefPubMed Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56:1104–6.CrossRefPubMed
Metadata
Title
Is Guillain–Barre syndrome following chickenpox a parainfectious disease? A case report and literature review
Authors
Bademain Jean Fabrice Ido
Sidi Mahamoud Guebre
Emeline Agathe Carama
Alfred Anselme Dabilgou
Christian Napon
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2023
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-023-03185-8

Other articles of this Issue 1/2023

BMC Neurology 1/2023 Go to the issue